Acknowledgements
DEFLECT
The DEFLECT is supported by grants from National Natural Science Foundation of China (No. 92169211). Jiangsu Pacific Meinuoke Biopharmaceuticals provided meplazumab. The views expressed in this article is the authors’ opinion, not the opinion or policy of funder.